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Summary. Background: The nutritional status of patients with cystic fibrosis (CF) is strongly
associated with pulmonary function, respiratory status and survival. Malnutrition could result from
a discrepancy between energy needs and food intake while malabsorption results from pancreatic
insufficiency which occurs in 85% of people with CF. Methods: A quality improvement (QI) project
was designed to improve the nutritional status of patients with CF with low BodyMass Index (BMI)
between 3 and 19 years of age. An algorithm was developed which included clinic-based
assessments of patients’ nutritional status and periodic assessment by a dietitian, social worker
and/or psychologist during the project. Gastrostomy tube placement and feeding was offered as a
last resort to improve caloric intake. Results: 173 patients seen during January–June, 2010, were
included in this project. They were classified into four BMI groups and data were collected
quarterly through June, 2012. The project target population (BMI percentile 24) had a median
BMI percentile at the start of the project of 11.8. At the end of the project median BMI percentile
was 22 (46% improvement). Conclusion: Improving nutrition and BMI for patients with CF is
achievable. Theremust be amotivated, multi-disciplinary team that includes patients and families.
A patient-specific combination of interventions must be used. These interventions could be quite
basic for patientswithBMI percentile25, yetmore elaborate for patientswithBMI percentile<25.
Clinic-based algorithms such as ours can successfully improve the BMI percentile in patients with
CF. Pediatr Pulmonol. 2015;50:544–551.  2014 Wiley Periodicals, Inc.
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BACKGROUND
Cystic Fibrosis (CF) is an autosomal recessive disease.
It is the most common life shortening disease in
Caucasians and also affects other ethnic groups.1 Median
life expectancy for patients with CF is 36.8 years of age in
2012.1 CF affects mainly the respiratory tract and
digestive system and to a lesser extent other systems in
the body.1 Lung disease is a major cause of morbidity and
mortality in patients with CF. Pulmonary function is the
primary predictor of death.2 The rate of pulmonary
function deterioration is the most important predictor of
deterioration.3 Nutritional status of patients with CF is
strongly associated with pulmonary function, respiratory
status, and survival.4 One of the ways to improve
pulmonary function and survival for patients with CF is
to improve their nutritional status. It has therefore been
recommended by the CF foundation (CFF) to maintain a
BMI  50th percentile for age given its association with
improved lung function.5
Despite extensive efforts to improve CF patient
nutritional status, less than half of the pediatric patients
with CF in the United States have a BMI50th percentile
for age.1,5 Malnutrition most likely results from a
discrepancy between energy needs and micronutrient
requirements and food intake. In addition, there is
malabsorption that results from pancreatic insufficiency
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which affects about 85% of patients with CF.5–7 Also,
patients with CF are at increased risk of other conditions
that may affect their nutritional status.8 CF related
diabetes (CFRD) is present in approximately 16% of the
CF population and has been linked to a decline in
nutritional status and lung function.9
The CFF recommends that intensive treatment with
both behavioral intervention and nutrition counseling be
used to promote weight gain in children 1–12 years of age
with growth deficits.5 For children with growth deficits
and adults with weight deficits, the CFF recommends the
use of nutritional supplements.5 Several studies were
conducted to evaluate behavioral intervention and
nutrition counseling in patients with CF 12 years of age
and younger.4,10,11 These studies demonstrated significant
improvement in patients’ behavior around meal time and
improvement in weight gain. On the other hand, one study
was conducted in adult patients with CF to assess a 10-
week home based behavioral nutrition intervention.12 The
study showed substantial improvements in the interven-
tion group’s specific CF nutrition knowledge and fat
intake, but no substantial change in BMI or health related
quality of life over time.
This is a prospective interventional project and was
done as part of quality improvement efforts at the
University of Michigan Pediatric Cystic Fibrosis Center
(CFC). The project was conducted to improve the overall
nutritional status of all pediatric patients with CF in the
center in an effort to improve BMI to 50th percentile and
above.
METHODS
Setting
This project was performed at the University of
Michigan C.S. Mott Children’s Hospital Cystic Fibrosis
Center (CFC). This is a relatively large CFC that follows
approximately 280 pediatric patients with CF and 480
individuals with CF in total. Adult patients are followed
by adult pulmonologists at this center.
Study Population
173 children and adolescents with a confirmed
diagnosis of CF, age 3–19 years of age attending our
center were included in the project. A CF diagnosis
was confirmed through positive sweat chloride testing
of 60meq/L and/or 2 CF disease causing mutations.
Median sweat chloride testing was 100.5mmol/L [Table 1].
Given that the focus was on BMI percentile, children ages
3 years of age and older were included. Patients were
divided into four groups according to their BMI percentile.
A color-coding system was utilized to quickly distinguish
each BMI percentile category for easier identification
by staff, patients and families. The BMI categories were:
50 percentile [blue], 25–49 percentiles [yellow], 10–
24 percentiles [orange], and <10 percentile [red]. Patients
in the lowest two groups [BMI 24 percentile] were
the specific target for the project. Project duration was
2.5 years.
Intervention: Clinical Pathway Development
A nutritional algorithm was developed to improve
weight gain and BMI for all patients, with special focus on
the targeted population [BMI 24 percentile]. Develop-
ing the algorithm helped in standardization of care
between team members. We also involved members of
our CF Family Advisory Board (FAB) to review the
algorithm so that they could provide the family
perspective on the strengths and pitfalls of the algorithm
before implementing the final version (Fig. 1).
The algorithm included assessment of patients’
nutritional status at their regularly scheduled quarterly
visits by the CFC registered dietitian. A high calorie diet
is recommended for all patients with CF especially with a
BMI 50 percentile. Estimated energy needs were in
accordance with CF dietary guidelines of 120–150% of
the recommended dietary allowance (RDA) per day.14
Oral supplements were recommended for the targeted
patients [BMI 24 percentile]. The recommended
amount of oral supplements per day was determined by
the caloric deficit to reach the patient’s daily energy
needs. Type of supplement and caloric density per ounce
was determined by our CFC dietitian. Detailed assess-
ment by a social worker and/or psychologist was done at
the start of the project and periodically to help identify
any obstacles to improved caloric intake. Appetite
stimulants were recommended to patients with poor
appetite. These included cyproheptadine as a first line
treatment. Mirtazapine was offered if there was a
concurrent diagnosis of depression and if it was clinically
recommended by the patient’s psychiatrist. Patients that
were not able to gain weight with the above measures
were recommended to be evaluated for gastrostomy tube
placement to help improve caloric intake through
nocturnal feeding.
ABBREVIATIONS:
BMI Body mass index
CF Cystic fibrosis
CFC Cystic fibrosis center
CFF Cystic fibrosis foundation
CFRD Cystic fibrosis related diabetes
FAB Family advisory board
FEV1% forced expiratory volume at 1 second, percent predicted
FEF25–75% forced expiratory flow between 25 and 75 percent of
exhaled volume, percent predicted
PDSA Plan-do-study-act
QI Quality improvement
SD Standard deviation
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All patients were given a weight gain goal per month at
each clinical visit. This ranged from 0.25 to 1.5 pounds
per month depending on the patient’s age and weight. The
team members worked with patients and families to
address any obstacles in obtaining supplements, medi-
cations or insurance coverage concerns to facilitate
access. Most of our intervention was clinic based. The
targeted patient population was monitored more frequent-
ly than the rest of the CF population for weight gain, BMI
and caloric intake when it was felt to be indicated. This
included monthly rather than quarterly visits or phone
calls to the family for updates on diet history and appetite.
Our pediatric psychologist and social worker, in addition
to the rest of the team, were available and offered follow
up between clinic visits to help troubleshoot with patients
and their families who were in greater need of assistance
to provide more ongoing support if necessary.
At each clinic visit, children ages 6 and older
underwent spirometry testing. Their FEV1% was fol-
lowed at each clinic visit and compared to previous values
to determine if these values were stable, improved or
worsened. Only results which met American Thoracic
Society criteria for interpretation were included in the
study for analysis. Children less than 6 years of age did
not undergo spirometry testing.
Several Plan-Do-Study-Act (PDSA) cycles were used
through the project duration to help address obstacles and
barriers and improve communication and access. The
team used a process run chart to test consistency between
teammembers in following the algorithm e.g. weight gain
goal documentation by the dietitian and by the providers
and communicating the information to patients and
families.
Project Timeline
A retrospective review of our CFC registry reports
(provided yearly by the CFF) from 2005 to 2008was done
with a focus on the BMI data for patients with CF between
3 and 19 years of age. The center datawas compared to the
median BMI for all CF Centers in the United States. A
comparison was also made to the top 10 performing CF
Centers nationwide. Although our overall BMI percentile
was above the national median from 2005 to 2008, it was
decided to undertake this project to in an effort to improve
the lowest two BMI groups followed by our center. Data
were collected quarterly from January 2010 through
June 2012 for analysis. BMI groups were determined
based on entry BMI percentile. All data analysis was
performed based on group assignment on project entry
TABLE 1—Patient Characteristics at Baseline
Patient characteristic*
Total
N¼ 173
Group 4
(BMI 50%ile)
N¼ 99
Group 3
(BMI¼ 25–49%ile)
N¼ 37
Group 2
(BMI¼ 10–24%ile)
N¼20 N¼ 17 P-value
Age at CF Diagnosis, years (median) 0.49 0.55 0.46 0.27 0.30 0.63
Age, years (median) 11.43 10.95 11.27 12.79 13.10 0.41
Age, years (%) 0.52
2–6 21.39 24.24 24.32 15.00 5.88
7–12 40.46 41.41 40.54 35.00 41.18
13–19 38.15 34.34 35.14 50.00 52.94
Height, percentile (median) 30.50 31.00 33.00 29.50 23.00 0.51
Weight, percentile (median) 46.00 64.00 38.50 19.50 6.0 <0.001
FEV (median) 92.50 96.00 93.00 79.00 76.00 <0.001
FEF 25–75 (median) 83.50 89.00 84.00 65.00 42.00 <0.001
Pseudomonas (%) 23.26 23.23 24.32 15.00 31.25 0.70
Sweat test, mmol/L (median) 100.50 100.00 101.50 104.00 101.00 0.99
Gender (%) 0.81
Male 49.13 48.48 56.76 55.00 47.06
Female 50.87 51.52 43.24 45.00 52.92
G-tube (%) 17.34 14.14 18.92 10.00 41.18 0.003
Appetite stimulant (%) 16.76 9.09 18.92 35.00 35.29 0.06
Pancreatic status (%) 0.92
Insufficient 83.77 82.76 87.50 80.00 86.67
Sufficient 16.23 17.24 12.50 20.00 13.33
Genetic Category (%) 0.012
Homozygous dF508 50.30 42.39 75.68 50.00 37.50
Heterozygous dF508 36.97 45.65 13.51 35.00 43.75
Other 12.73 11.96 10.81 15.00 18.75
*Missing Data: 2 age of diagnosis, 3 from height and weight percentile, 19 from FEF and FEV, 1 from pseudomonas, 37 from sweat test, 19 from
pancreatic status, 8 from genetic category.
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(i.e. group assignment was fixed for the duration of the
project).
Statistical Analysis
BMI percentile is expressed as percentile based on
CDC pediatric growth charts. Spirometric measures of
lung function are reported as percent predicted values
(NHANESIII). Differences in distribution of baseline
characteristics by BMI group were calculated using the
Wilcoxon rank sum test, chi-square test or Fisher’s exact
test based on the distribution of the variable. Mixed
effects models were used to model the association
between BMI percentile and FEV1 %levels over time
controlling for initial BMI percentile group, age, gender,
genetic group, and whether one had a g-tube or not. Time,
age, and gender were always kept in the models due to
possible confounding, but genetic group and having a g-
tube only remained in the model if P< 0.2.
To investigate the effect of our intervention,wemodeled
thepatternofBMIpercentiles over time according to initial
BMI percentile group with a mixed model. This model
accounted for random effects of time and a random
intercept (starting BMI percentile), as well as the fixed
effects of gender and age. Since the visits were not equally
spaced for all patients (approximately quarterly), time
entered the equation as a continuous fixed variable as
months from baseline, as well as a random effect. The
interaction between months from baseline and BMI group
was included to assess if there were different changes in
BMI percentiles over time for each BMI group.
Additionally, we were interested in the association of
our intervention, BMI percentiles, and lung function. To
analyze this, we ran a mixed model on the lung function
outcome to see the association with time (months from
baseline, entered with linear and quadratic terms) and
BMI percentile (as it changed over time for all
individuals) controlling for age and gender. We allowed
for a random intercept and slope of the linear time
variable. FEF25–75% and FEV1% had strong positive
Pearson correlation ranging from 0.75 to 0.82 over the
entire time period (P< 0.0001 for each time point). Due
to this high correlation between FEV1% and FEF25–75%
we presented results only for the model with FEV1% and
found similar results (not shown) for FEF25–75%.
All analyses were done in SAS v9.3. The Institutional
Review Board waived oversight for the quality improve-
ment project and analysis.
Fig. 1. CF nutritional algorithm.
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RESULTS
173 children ages 3–19 years were seen in our CF
center during the enrollment period of the project, January
through June, 2010, and were therefore included.
Patient demographics are listed in Table 1 for the
overall population, as well as the four BMI categories.
The median age of this sample was 11.4 years with about
equal numbers of males and females. There were no
differences in age, sweat test value, or gender. Therewas a
statistical difference in genetic category between the
groups such that those in the 25–49% range are more
likely to be homozygous dF508. However, if BMI groups
are split by less than 25th percentile versus greater than or
equal to the 25th percentile, there is no significant
difference in genetic group distribution by BMI percentile
group, P¼ 0.63 [Data not shown], so this may be a
spurious finding.
Table 2 summarizes the results from a mixed model
investigating the pattern of BMI percentiles over time for
patients by initial BMI group. After accounting for age
and gender, the interaction between months from baseline
and initial BMI group was significant, P¼ 0.019, On
average, for those who began with a BMI percentile less
than 10, BMI percentile increased by 0.29 every month
(P¼ 0.033), for those who began with BMI in the 10th–
24th percentile, BMI percentile increased each month by
0.26 (P¼ 0.034), and for those who began with BMI
percentile between 25 and 49, BMI percentile increased
by 0.18 (P¼ 0.031). Therefore, therewas a slight increase
in BMI in all groups with less than 50th BMI percentile
and slight, but not significant, decrease in BMI percentile
for those with greater than 50th percentile (decrease of
0.13 BMI percentile for each month, P¼ 0.10). This can
be seen in Figure 2 which presents the mean BMI
percentiles over time by initial BMI percentile groups.
There is not large movement in the average BMI
percentile for groups who started with greater than 25th
BMI percentile, but there is increase over time in those
who began with lower BMI percentiles.
Since we targeted those who began with BMI less than
the 25th percentile,we show the proportionof patientswith
this low of BMI throughout the duration of the study in
Figure 3. We see that these low BMI patients make up
almost a quarter of our sample at the beginning, but this
generally decreases over time to less than 20%. We note
that of thosewho beganwith BMI percentile less than 10, 7
(41%) finished the study with BMI percentile between 10
and 53. Of those who began in the 10–24 percentile, 15
(75%) maintained or gained BMI percentile ranging from
10 to 69. Of thosewho started in the 25–49th percentile, 32
(86%) finished the study in the 25–50th percentile. Finally,
82 (83%) of those who began with BMI percentile greater
than50, ended the studywithBMIpercentile from50 to71.
Median FEV1% levels were higher for children with
higher BMI percentile levels (Fig. 4) over time. For those
who began with BMI less than the 25th percentile, on
average FEV1% values were around or less than 80%. In
contrast, for thosewhobeganwithBMI at the 25th percentile
or greater, median FEV1% ranged from 90 to 100%. In the
model, therewas a significant decrease in FEV1% in the first
month of 0.41 (P¼ 0.0001) with less of a decrease as time
went on (decreasewas 0.20 at one year and a slight increase
of 0.03 at the end of two years, P¼ 0.012) controlling for
BMI percentile, age and gender. Thus, holding gender and
age constant, FEV generally decreased during the course of
the study, but by less than 5 points for all groups. BMI
percentile and age were independently significantly
associated with FEV1% levels over time. Specifically,
increasing BMI percentile was associated with increasing
lung function such that for each increase in BMI percentile,
FEV1% increased by 0.18 (P< 0.0001). In contrast,
increasing age was associated with decreased lung function
such that each additional year older was associated with a
decrease of 0.95 in lung function (P¼ 0.001).
DISCUSSION
In our QI project we found that improving BMI for our
patients with CF who began with BMI less than the 25th
TABLE 2—Results from Mixed Model of BMI Percentile by Initial BMI Percentile Group
Variable Estimate Standard error P-value
Intercept 76.92 2.98 —
Months from baseline 0.13 0.08 0.031
BMI Group (vs. 50%ile) <0.0001
<10%ile 67.93 3.82
10–24%ile 51.81 3.55
25–49%ile 32.75 2.80
Months* BMI Group 0.019
Months*< 10%ile 0.42 0.20 0.033
Months*< 10–24%ile 0.39 0.18 0.034
Months*< 25–49%ile 0.31 0.14 0.031
Male (vs. Female) 1.50 1.93 0.44
Age (in years) 0.11 0.22 0.63
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percentile was achievable. This was possible by using
several strategies. An important strategy was to standard-
ize the CF center faculty and staff in following one
algorithm in addition to the rest of the QI project. Another
strategy was to include the CF FAB in developing the
intervention steps and algorithm. In addition, buy in from
patients and families was crucial to the success of the
project. Throughout the QI project duration, team
members were regularly updating patients and families
with progress. The medical team was updated periodical-
ly about the overall progress through monthly meetings.
Sharing problems and/or success stories occurred during
these meetings as well. Implementation of the algorithm
required collaboration between all team members, FAB,
patients and families. Empowering not only our staff, but
also patients and families to follow the algorithm through
persistence and consistency was key in the success of this
project.
We found a significant improvement of BMI percentile
for those who began with BMI less than 10, those with
BMI in the 10th–24th percentile and those with BMI in
the 25th–49th percentile over the project duration. This
improvement was independent of age and gender and both
of these characteristics were not significantly associated
with a change in BMI percentile. This improvement was
the result of the dedication of all that were involved buy in
from patients and families, and multi-factorial approach.
When compared to other studies that aimed to improve
nutrition and/or BMI for their patients, our QI project was
distinct with respect to a couple of factors. First, the type
of intervention in some studies has focused on using
behavior modification as a means to improve nutri-
tion.4,10,11 These studies included children 12 years of age
and younger. Our project employed a multi-factorial
approach to improve BMI. One of these strategies was an
intervention by our psychologists and social workers to
help address any issues related to the demand of the need
to increase calorie intake. Counseling was done through-
out the project duration. We chose to focus on children
Fig. 2. Mean BMI percentiles for each initial BMI percentile group over study period.
Fig. 3. Proportion of patients with BMI <25th percentile over
study period.
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and adolescents between the ages of 3 and 19 years. The
median age of children in the targeted lower two BMI
groups, BMI 10–24% and <10%, was 12.79 and 13.10
years respectively. Overall, the median age was 11.43
years for all participants. Also, these studies had a limited
number of subjects and were of relatively short duration
while our project was long-term and included a large
number of patients.
Several reviews and consensus reports were published
to evaluate nutrition-related management of patients with
CF.5,13,14 They all emphasized the need for regular
evaluation of patient’s nutritional status, the need for a
high-calorie diet and the relationship between good
nutritional status and quality of life. A project was
performed to improve adherence to pancreatic enzyme
replacement therapy (PERT) in pancreatic insufficient
preadolescent patients with CF. Educational and behav-
ioral interventions resulted in increasing adherence to
PERTand increasing caloric intake as well.15 Two studies
reported adopting a standard approach to nutritional
assessment and treatment.16,17 This led to significant
improvement in nutritional outcomes of patients with CF.
Our standardized approach in addition to regular
evaluation (and additional evaluation as needed) to
address the nutritional needs of the patients resulted in
achieving our goal of improvement in median BMI in our
CF Center similar to other studies
Lung function, although not a primary outcome of our
project, was evaluated to determine if the gains in BMI
percentile in the lower groups corresponded to improve-
ment in lung function. Over the duration of the project,
FEV1% and FEF25–75% across all groups remained steady
without significant improvement. The fact that we did not
see clinically significant improvement in lung function is
likely due to the relatively short duration of the project
and the relatively small number of patients included. It is
difficult to extrapolate whether a longer time period of
monitoring would demonstrate a significant change.
CONCLUSION
Improving median BMI for a CF center is achievable in a
well-structuredQIproject involvingmanyplayers.Thekey to
improving nutrition and BMI for children with CF is multi-
factorial. There must be a motivated, multidisciplinary team.
Collaboration with patients and families is crucial for the
team to gain their feedback and provide them with their
expertise to make goals attainable and sustainable. Avariety
of interventionsmust be used tofind the right combination for
the younger and older population. These interventions could
be less for those patients who are able to maintain their BMI
percentile at 25 or higher, but are much more elaborate and
aggressive when a person’s BMI percentile is less than 25.
These interventions should always be tailored to the patient
based on their need and motivation. We believe that a clinic-
based algorithm such as ours can be successful in improving
the BMI percentile of patients with CF.
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